Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGLO.L Regulatory News (GLO)

  • There is currently no data for GLO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/RI) - ContourGlobal plc

1 Dec 2022 10:13

RNS Number : 2528I
JPMorgan Securities Plc
01 December 2022
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

J.P. Morgan Securities Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

ContourGlobal plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Financial Adviser to Cretaceous Bidco Limited

(d) Date dealing undertaken:

30 November 2022

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

1p ordinary

Purchase

 

Sale

108,275

 

93,607

2.5050 GBP

 

2.5002 GBP

2.5000 GBP

 

2.4998 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

1p ordinary

Equity Swap

Decrease Short

 

 

Increase Long

 

Increase Short

 

 

1,000

1

 

285

 

2,928

3,811

5,868

2.4998 GBP

2.5000 GBP

 

2.4998 GBP

 

2.5000 GBP

2.5002 GBP

2.5048 GBP

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

1 December 2022

Contact name:

Alwyn Basch

Telephone number:

020 7742 7407

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERFSEFSFEESEFE
Date   Source Headline
5th May 20205:24 pmRNSTransaction in Own Shares
4th May 20205:40 pmRNSTransaction in Own Shares
1st May 20206:25 pmRNSTransaction in Own Shares
1st May 20209:18 amRNSTotal Voting Rights
30th Apr 20206:00 pmRNSTransaction in Own Shares
28th Apr 20205:31 pmRNSTransaction in Own Shares
27th Apr 20205:41 pmRNSTransaction in Own Shares
24th Apr 20206:03 pmRNSTransaction in Own Shares
23rd Apr 20205:51 pmRNSTransaction in Own Shares
22nd Apr 20206:01 pmRNSTransaction in Own Shares
21st Apr 20205:13 pmRNSTransaction in Own Shares
21st Apr 20207:00 amRNSTransaction in Own Shares
17th Apr 20206:16 pmRNSTransaction in Own Shares
16th Apr 20206:11 pmRNSTransaction in Own Shares
15th Apr 20206:07 pmRNSTransaction in Own Shares
15th Apr 20207:30 amRNSTransaction in Own Shares
9th Apr 20205:16 pmRNSTransaction in Own Shares
8th Apr 20206:09 pmRNSTransaction in Own Shares
7th Apr 20205:35 pmRNSAnnual Financial Report
7th Apr 20205:31 pmRNSDirector/PDMR Shareholding
6th Apr 20205:54 pmRNSTransaction in Own Shares
3rd Apr 20206:15 pmRNSTransaction in Own Shares
3rd Apr 20204:35 pmRNSPrice Monitoring Extension
2nd Apr 20206:24 pmRNSTransaction in Own Shares
1st Apr 20206:21 pmRNSTransaction in Own Shares
1st Apr 20207:00 amRNSShare buy-back programme of up to £30 million
23rd Mar 20204:41 pmRNSSecond Price Monitoring Extn
23rd Mar 20204:38 pmRNSPrice Monitoring Extension
17th Mar 20207:01 amRNSPreliminary Results Announcement
17th Mar 20207:00 amRNSQuarterly Dividend Update
9th Mar 20208:00 amRNSNotice of Annual Results Announcement
5th Feb 202012:07 pmRNSSecond Price Monitoring Extn
5th Feb 202012:02 pmRNSPrice Monitoring Extension
20th Jan 20207:00 amRNSContourGlobal announces reporting dates for 2020
16th Dec 20197:00 amRNSCurrency Conversion Rate For Q3 2019 Dividend
5th Dec 20197:00 amRNSTrading Update
2nd Dec 201912:53 pmRNSAppointment of new Head of Investor Relations
25th Nov 20196:32 pmRNSClosing of Acquisition of CHP Portfolio from Alpek
10th Oct 20191:44 pmRNSDirectorate Change - Committee Memberships
1st Oct 20194:41 pmRNSSecond Price Monitoring Extn
1st Oct 20194:35 pmRNSPrice Monitoring Extension
18th Sep 201912:07 pmRNSSecond Price Monitoring Extn
18th Sep 201912:02 pmRNSPrice Monitoring Extension
12th Sep 20194:35 pmRNSPrice Monitoring Extension
5th Sep 201912:07 pmRNSSecond Price Monitoring Extn
5th Sep 201912:02 pmRNSPrice Monitoring Extension
4th Sep 201912:02 pmRNSPrice Monitoring Extension
19th Aug 20191:58 pmRNSConversion Rate for Interim Dividend
12th Aug 20197:00 amRNSDirector/PDMR Shareholding
9th Aug 201911:15 amRNSResignation of Non-Executive Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.